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Abstract 
Background: Transcriptional reprogramming is a fundamental process of living cells in order to adapt to environ-
mental and endogenous cues. In order to allow flexible and timely control over gene expression without the interfer-
ence of native gene expression machinery, a large number of studies have focused on developing synthetic biology 
tools for orthogonal control of transcription. Most recently, the nuclease-deficient Cas9 (dCas9) has emerged as a 
flexible tool for controlling activation and repression of target genes, by the simple RNA-guided positioning of dCas9 
in the vicinity of the target gene transcription start site.
Results: In this study we compared two different systems of dCas9-mediated transcriptional reprogramming, and 
applied them to genes controlling two biosynthetic pathways for biobased production of isoprenoids and triacylg-
lycerols (TAGs) in baker’s yeast Saccharomyces cerevisiae. By testing 101 guide-RNA (gRNA) structures on a total of 14 
different yeast promoters, we identified the best-performing combinations based on reporter assays. Though a larger 
number of gRNA-promoter combinations do not perturb gene expression, some gRNAs support expression pertur-
bations up to ~threefold. The best-performing gRNAs were used for single and multiplex reprogramming strategies 
for redirecting flux related to isoprenoid production and optimization of TAG profiles. From these studies, we identi-
fied both constitutive and inducible multiplex reprogramming strategies enabling significant changes in isoprenoid 
production and increases in TAG.
Conclusion: Taken together, we show similar performance for a constitutive and an inducible dCas9 approach, and 
identify multiplex gRNA designs that can significantly perturb isoprenoid production and TAG profiles in yeast without 
editing the genomic context of the target genes. We also identify a large number of gRNA positions in 14 native yeast 
target pomoters that do not affect expression, suggesting the need for further optimization of gRNA design tools and 
dCas9 engineering.
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Background
Control of gene expression largely impacts how living 
organisms adapt to environmental changes, differences 
in metabolic fluxes, and developmental cell states [1–3]. 
In order to provide an optimal response to such exter-
nal and internal cues, eukaryotes orchestrate complex 
transcriptional programs in multiple genomic loci simul-
taneously [4].
For development of cell factories, balanced expression 
between genes encoding native enzymes of metabolic 
pathways and heterologous genes encoding multi-step 
biosynthetic pathways have been explored in order 
to increase productivity [5–7]. Yet, due to the lack of 
orthogonal and tuneable transcriptional control mecha-
nisms, metabolic engineers often adopt a few somewhat 
characterized promoters for driving the expression of 
biosynthetic pathway genes, albeit without predictive 
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understanding of expression levels of single genes crucial 
for optimal production.
In the budding yeast Saccharomyces cerevisiae the 
mevalonate (MVA) pathway generates precursors isopen-
tenyl diphosphate (IPP) and dimethylallyl pyrophosphate 
(DMAPP) from acetyl-CoA through seven enzymatic 
reactions [8]. Several studies have reported the overex-
pression and downregulation of key MVA pathway genes, 
including the ones encoding farnesyl pyrophosphate 
(FPP) synthase (ERG20), squalene synthase (ERG9), and 
the HMG-CoA reductase (HMG1), in order to increase 
production of value-added isoprenoids from simple sug-
ars, while simultaneously maintaining ergosterol levels to 
support growth [9–11].
In another example, triacylglycerols (TAGs) are key 
molecules for cell functioning as essential energy stor-
age compounds, and also potential industrial feedstocks 
for the production of food ingredients, oleochemicals 
and biodiesel [12, 13]. TAG biosynthesis involves several 
genes from the lipid metabolic pathway, including those 
encoding the delta-9 desaturase (OLE1) and the diacyl-
glyceride acyl-transferase (DGA1) [14, 15], and it has 
been demonstrated that regulating these two genes dra-
matically affect lipid composition of the cell [16, 17]. In 
both examples, increased productivity of isoprenoids and 
TAGs need to be balanced by cell membrane integrity 
and growth. This calls for the development and applica-
tion of new molecular tools to enable testing and iden-
tification of optimal expression levels of several genes 
simultaneously.
In recent years, the use of endonuclease-deficient, yet 
RNA-binding, Cas9 variants (dCas9) has shown tunable 
and orthogonal control of gene expression by blocking 
transcription elongation [18, 19]. The mechanism for 
directing dCas9 to multiple genes at the same time is 
identical to that of Cas9, namely by the use of sequence-
specific Cas9-binding guide RNAs (gRNAs) [19]. In 
terms of regulatory action, the repressive nature of 
dCas9, termed CRISPR (Clustered Regularly Interspaced 
Short Palindromic Repeats) interference (CRISPRi), has 
been improved by fusing dCas9 with repressive chroma-
tin modifier domains, like the KRAB (Krüppel associated 
box) domain of Kox1, and the mammalian transcrip-
tional repressor domain Mxi1 [18]. Likewise, to repur-
pose dCas9 for gene activation, dCas9 has been coupled 
to transcription activators, like VP64 and p65AD, thereby 
upregulating gene expression up to 25-fold when using 
multiple gRNAs in proximity to the transcription start 
site (TSS) of single target gene promoters [18, 20–22]. 
In addition to regulatory action, placing either dCas9 
or gRNA expression under the control of an inducible 
promoter has enabled dose- and time-dependent tun-
ing of target gene expression [19, 23]. More recently, the 
engineering of gRNA into scaffold RNA (scRNA), which 
mediates the assembly of dCas9 and other RNA-binding 
proteins fused to transcription regulatory domains like 
KRAB and VP64, has enabled both target specificity and 
regulatory function in the assembled “master-regulator” 
[24]. Cells expressing such systems allow some genes to 
be activated and others to be repressed as determined by 
the scRNAs, and not dCas9 itself [24].
Here we present the use of two dCas9-mediated sys-
tems for controlling expression of genes targeted by 
gRNAs. One system relies on the anhydrotetracycline 
(aTc)-inducible expression of gRNA expression and 
dCas9 fused to either Mxi1 or VPR (VP64-p65-Rta) [25] 
for repression or activation of target gene expression, 
respectively. The second system has constitutive expres-
sion of scRNAs, which link both target site and regu-
latory action to gene expression. The first system is an 
extension from the inducible CRISPRi system developed 
by Smith et al., whereas the constitutive system is further 
developed from the RNA scaffolding outline developed 
by Zalatan et al. [23, 24]. We show that the two systems 
mediate similar quantitative changes in both repression 
and activation of two target promoters, and that the two 
systems can be used for single and multiplex transcrip-
tional reprogramming of biosynthetic pathways in yeast. 
We use budding yeast S. cerevisiae as a testbed chassis 
to test >100 gRNAs positioned along 14 different pro-
moters with basal expression spanning >2.5 orders of 
magnitude. The gRNAs are able to guide dCas9-medi-
ated activation and repression of gene expression up to 
2.5- and 3-fold, respectively. We also demonstrate the 
impact of single and multiplex gRNA and gRNA strate-
gies for reprogramming expression of multiple genes in 
the isoprenoid and TAG biosynthetic pathways. Finally, 
we report targeted multi-gene expression reprogram-
ming to significantly regulate carotenoid production and 
TAGs profile.
Results
Benchmarking two systems for dCas9‑mediated gene 
regulation
In order to test dCas9-mediated gene expression in yeast, 
we initially chose two different approaches (Fig. 1). In one 
approach, we placed gRNA expression downstream of an 
aTc-inducible element to control onset of gene regula-
tion. Adding this degree of control allows investigation of 
immediate effects on gene expression, and impact from 
timing gene regulation on growing cultures. We used 
the previously reported construct dCas9-VPR, which 
cooperatively recruits transcription machinery for acti-
vation [25], and dCas9-Mxi1 for repression as previously 
described [18]. This approach is referred herein as the 
“inducible system” (Fig. 1a).
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In another approach, we leveraged RNA-scaffolds built 
into the original gRNA structure to facilitate recruitment 
of either VPR or Mxi1 [24]. VPR and Mxi1 were fused to 
the orthogonal scaffold-binding domains MCP and PCP, 
respectively, making simultaneous bi-directional and tar-
geted gene regulation possible (Fig.  1b). In our design, 
GS-NLS constituted the linker between MCP and VPR, 
and we used 3× GS as the linker between PCP and Mxi1. 
Expression of genomically integrated MCP–VPR and 
PCP-Mxi1 were controlled by ADH1 promoters, pADH1. 
Transcriptional regulation from this system is activated 
after introducing plasmid-borne dCas9, and a plasmid 
containing one or more constitutively expressed scRNAs. 
Herein, we refer to this approach as the “constitutive 
system”.
We compared the inducible and constitutive systems 
by targeting two yeast promoters involved in either 
fatty acid synthesis (pOLE1) or the mevalonate pathway 
(pHMG1) (Fig. 1c). For our analyses, we designed gRNAs 
that localize mainly between −200 and +1 nucleotides 
(nt) relative to the transcription start site (TSS; TSS-200 
and TSS+1), which was previously reported to be the 
region to most likely influence transcriptional regula-
tion using dCas9-mediated reprogramming [23]. For our 
gRNA designs we assessed self-complementarity and off-
targets by CHOPCHOP (http://chopchop.cbu.uib.no) 
and the algorithm from Smith et al. (http://lp2.github.io/
yeast-crispri/) [23, 26] (Additional file 1: Table S4). These 
software packages also provided predicted nucleosome 
occupancy and chromatin accessibility. Next, we con-
structed the pOLE1-GFP and pHMG1-GFP reporter cas-
settes and stably integrated these into the yeast genome. 
Twenty-four hours following either (1) aTc treatment or 
(2) dilution to OD ~0.2 for the constitutive system, mean 
fluorescence intensity (MFI) was quantified. The four 
strains tested using the inducible system were compared 
to non-induced control strains, while MFI from strains 
constructed for testing the constitutive system were 
scored relative to strains with an empty gRNA plasmid. 
In the aTc-inducible system, expression from pHMG1 
was reduced ~1.5-fold and activated ~1.6-fold in strains 
expressing dCas9-Mxi1 and dCas9-VPR, respectively 
(Fig.  1c), while the constitutive system conferred ~1.2-
fold repression and ~1.3-fold activation using scRNAs for 
tethering dCas9-Mxi1 or dCas9-VPR, respectively, to the 
pHMG1 promoter. For pOLE1, the inducible system con-
ferred no significant activation using dCas9-VPR, while 
induced expression of the gRNA guiding dCas9-Mxi1 
resulted in 2.6-fold repression. When targeting pOLE1, 
the constitutive system did not enable activation, but 
resulted in significant repression (Fig. 1c).
To evaluate if the dCas9 systems would affect growth 
when regulating native genes, we tested the growth 
kinetics of the strains subjected to either of the two regu-
latory systems. Here, we found no impairment in growth 
rates relative to control strains upon targeting pHMG1 
or pOLE1 for regulation (Additional file  2: Figure S1). 
On contrary, the inducible system improved growth in 
some strains. Additionally, when evaluating expression 
of reporter genes from the two different promoters in 
the two systems, we observed that changes in expression 
were maintained for more than 24  h (Additional file  3: 
Figure S2).
Taken together, using the same gRNAs and dCas9 vari-
ant, the relative MFIs were comparable between the two 
systems for pOLE1. For pHMG1 the inducible system 
performed slightly better than the constitutive system. 
Also, for none of the two systems did the synthetic tran-
scriptional reprogramming confer any growth reduction 
when targeting pHMG1 and pOLE1.
Regulating gene expression using the constitutive system
In order to further assess the regulatory potential of the 
two systems, we tested the constitutive system on a larger 
set of MVA and glycolytic promoters. The carotenoid 
pathway from Xanthophyllomyces dendrorhous has been 
extensively used as an efficient screening assay for tran-
scription-based MVA pathway flux in S. cerevisiae [27, 
28]. Likewise, tuning expression of MVA genes to control 
flux through the MVA pathway was previously adopted 
to optimize artemisinin production [29]. Hence, we pur-
sued identifying gRNA entry points for transcriptional 
regulation of MVA pathway promoters (Fig. 2a). In addi-
tion to MVA target genes, our candidate set of promoters 
(See figure on previous page.) 
Fig. 1 Comparing two dCas9 systems for transcriptional regulation. a The anhydro-tetracyclin (aTc) inducible system with gRNA expression con-
trolled by TetO reprograms transcriptional expression with dCas9 directly fused to either VPR or Mxi1 anchoring to promoters of genes of interest 
(GOI). b The constitutive dCas9 and scRNA expression system regulates transcription through orthogonal gRNA scaffold extensions that recruit 
endogenously transcribed Mxi1 or VPR. Two identical effectors can be recruited per scRNA. Introducing dCas9 and scRNA(s) promote the onset 
of this system. For both the inducible and the constitutive system Mxi1 (red) is used for repression and VPR (green) for activation. c Benchmarking 
the inducible and the constitutive system. BioLector data from time-point 24 h are shown for both systems as relative MFI compared to controls. 
Control levels are shown in black, repression in light grey and activation in dark grey. Results are presented as GFP/OD from targeting the GFP-fused 
promoters HMG1 at position TSS-128 and OLE1 at position TSS-381 in both systems. MFI values are shown as mean ± S.D. from three (n = 3) bio-
logical replicate experiments
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also included commonly used strong glycolytic and weak 
promoters (pTDH3, pTEF1, pPGK1, and pRNR2) [28].
For 12 native yeast promoters we designed 44 gRNAs 
to combine with the 2× PP7 or 2× MS2 (wt + f6) RNA 
scaffolds totalling 88 scRNAs (Additional file  4: Figure 
S3, Additional file 1: Table S4). Twenty-four hours follow-
ing liquid culture dilution (OD~0.2) of dCas9 and scRNA 
transformed cells we measured fluorescence intensi-
ties from our reporter promoters. From our analyses the 
regulation capacity was observed to range from threefold 
repression to 2.3-fold activation for the best-performing 
scRNAs for each promoter. More specifically, among 
these designed scRNAs, significant repression of pro-
moter activity of the strong pTDH3 promoter and the 
medium strength promoters pERG20, pERG12, pERG9 
and pHMG1 were observed (Fig.  2a), while significant 
activation of promoter activity was only observed for 
pHMG1 and pERG9. However, as evidenced from the 
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Fig. 2 Analyzing transcriptional regulation on yeast promoters using the constitutive system. a Log-scaled mean fluorescense intensity for 12 yeast 
promoters involved in glycolysis and mevalonate metabolism is shown. Activation with MCP-VPR (dark grey) and repression with PCP-Mxi1 (light 
grey) is shown next to ‘no gRNA’ controls (black; dCas9 expressed) for best performing scRNAs out of 88 for each promoter. Asterisks indicate regula-
tion that resulted in significantly altered expression profiles relative to controls (*p < 0.05). MFI values are shown as mean ± S.D. from three (n = 3) 
biological replicate experiments. b Best performing scRNAs for repression (light grey) and for activation (dark grey) are the same as presented in a. 
Relative MFI (deviation from ‘no gRNA’ control strains Sc-23 to Sc-34 expressing dCas9) conferred by 88 scRNAs (in strains Sc-35 to Sc-122) tethering 
dCas9 and PCP-Mxi1 or MCP-VPR on a total of 12 promoters is illustrated in black relative to PAM distance (nt) from TSS+1
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total set of tested scRNAs, for some promoters none of 
the tested scRNAs were able to significantly perturb pro-
moter activity as inferred from reporter assays (Fig.  2a; 
Additional file  4: Figure S3). In total, 29 out of 88 scR-
NAs conferred significant regulation (Additional file  4: 
Figure S3). Our analyses also revealed that even VPR in 
combination with some scRNAs can confer repression of 
some promoters (e.g. pERG20 and pERG12), which sup-
ports a previous study [30]. Our most impactful scRNA 
for activation hybridizes to pERG9 (~2.3-fold) at TSS-
148 and localizes within a previously identified UAS [31], 
while the strongest repression on pERG9 (~2.3-fold) was 
observed from targeting position TSS-66 not overlapping 
with any annotated promoter elements. Likewise, span-
ning the TATA-box with the scRNA positioned at TSS-
23 did not facilitate activation or repression.
Targeting transcriptional effectors to promoters between 
TSS-200 and TSS+1 was previously reported to impact 
expression [23]. Most of our compiled data were sampled 
in this region, and for the few data points sampled exceed-
ing TSS-200 none conferred significant regulation (Fig. 2b). 
For scRNAs targeting within the TSS-200 to TSS+1 win-
dow, we observed no correlation between the scRNA posi-
tion and their impact on transcriptional regulation (Fig. 2a, 
b). In addition to most of the scRNAs targeting sequences 
upstream of TSS+1, we also selected a few scRNAs tar-
geting downstream TSS+1. For those designed to target 
dCas9 downstream of the TSS+1, the scRNA targeting the 
template strand at position TSS+21 of pERG12 was the 
most impactful resulting in significant repression (Addi-
tional file  4: Figure S3). In contrast, we found for several 
promoters (pERG20, pERG9, pERG8, and pBTS1) in which 
scRNAs targeted the non-template strand downstream of 
TSS+1, no significant repression. This finding deviates 
from previous reports focusing on transcriptional regula-
tion in bacteria [19, 32], but falls in line with similar studies 
on yeast ERG11 and ERG25 transcriptional regulation [23].
To further analyse the observed regulation patterns, 
we compared the change in promoter activity when 
using individual scRNA to the predicted nucleosome 
positioning (Additional file 5: Figure S4) [33]. We found 
that positioning of scRNAs in regions with predicted 
low nucleosome occupancy for pHMG1 correlated with 
higher transcriptional impact in accordance with current 
literature [23, 34, 35]. For pERG9, designing scRNAs to 
target nucleosome-free vs. nucleosome-dense regions 
did not change their impact on transcriptional impact, 
and investigation of all promoters revealed no overall 
correlation between transcriptional impact and scRNA 
positioning in relation to predicted nucleosome position-
ing (Additional file  5: Figure S4). However, it should be 
mentioned that for pHMG1 and pERG9, the nucleosome 
positioning landscape is based on S288C genome data.
In summary, from testing a total of in silico designed 88 
scRNAs on 12 native yeast promoters using the consti-
tutive system, we observed significant repression of five 
promoters and activation of two promoters, at a maxi-
mum fold-change of 3- and 2.3-fold, respectively. Also, 
our study identified no clear correlation between tran-
scriptional impact and scRNA positioning in relation 
TSS, nor correlation between scRNA positioning and 
predicted nucleosome positioning.
Regulating expression of TAG biosynthetic genes using the 
inducible system
From our initial benchmark of the two dCas9 systems the 
inducible system could efficiently regulate the expression 
of pOLE1 (Fig.  1c). To further test the applicability of 
this system, we characterized more gRNAs targeting the 
pOLE1 promoter. Likewise, we designed several gRNAs 
targeting the pDGA1. Activation or induction of pOLE1 
and pDGA1 activity has previously been shown to 
increase TAG biosynthesis [16, 17], and we therefore first 
tested the induction of gRNAs together with expression 
of dCas9-VPR (Fig. 1a).
Similar to the constitutive system, we coupled pDGA1 
and pOLE1 to GFP expression to quantitatively deter-
mine interference capacities of several different gRNAs 
(Fig.  3a). Here, gRNAs targeting pDGA1 at positions 
TSS-139 and TSS-58 gave the highest upregulation with 
up to twofold activation (Fig. 3a). For pOLE1, the strong-
est activation was obtained with a gRNA binding at posi-
tion TSS-381 (2.5-fold). For pOLE1, the gRNA closest 
to TSS+1 is positioned at TSS-29, and it slightly down-
regulates GFP expression (Fig.  3b). Further analysis of 
position TSS-381 showed the strongest activation poten-
tial around twenty-four hours following aTc-induction 
(Fig.  3c). As shown in the control, when no gRNA was 
expressed, a time dependent regulation of pOLE1 was 
observed (Fig.  3c). This is in line with a time-resolved 
quantitative analysis performed by Casanovas et al. [36], 
where it was demonstrated that OLE1 is highly expressed 
during early-phase to mid-exponential phase and down-
regulated from late exponential phase. As such, in addi-
tion to endogenous growth phase-dependent regulation, 
our temporal analysis showed that gRNA-mediated tun-
ing of gene expression is able to downregulate and upreg-
ulate pOLE1 activity (Fig. 3c).
Targeted regulation of biosynthesis by dCas9 
and combinatorial gRNA strategies
In order to translate the observed effects from our 
reporter assays into reprogramming biosynthetic path-
way flux, we next decided to investigate if the best-per-
forming gRNAs would enable regulation of flux towards 
biosynthesis of either carotenoid or TAGs. With respect 
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to the former, we first coupled the MVA pathway to 
carotenoid production using the strong glycolytic pro-
moters, pPGK1 and pTDH3 already tested (Fig.  2a), to 
drive the expression of the gene encoding geranylgeranyl 
diphosphate synthase (BTS1) and those encoding Xan-
thophyllomyces dendrorhous lycopene cyclase/phytoene 
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b, asterisks indicate significant regulation relative to controls (*p < 0.05)
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synthase (crtYB and crtI), respectively (Fig. 4a). The het-
erologous carotenoid pathway competes with sterol syn-
thesis for the common precursor FPP, and repression of 
pERG9 has previously been shown to direct pathway flux 
towards isoprenoid production, while tuning the activity 
of pERG20 and pHMG1 has also been used to perturb 
MVA pathway flux [7, 29].
Next we analysed the effect of single gRNA expres-
sion on carotenoid production as inferred by pheno-
typic changes, using our 9 best-performing scRNAs 
targeting pERG20, pTDH3, pERG12, pERG9, pPGK1, 
and pHMG1 (Fig.  4b). From our experiment, the two 
scRNAs targeting dCas9 and PCP-Mxi1 to pERG20 at 
position TSS-86 and pTDH3 at position TSS-107, were 
able to modestly decrease the carotenoid-associated 
orange phenotype (Fig.  4b). Vice versa, targeting dCas9 
and MCP-VPR to pHMG2 at position TSS-140 enabled 
modest increase in the carotenoid-associated pheno-
type (Fig.  4b). To further boost transcriptional impact 
for re-directing pathway flux, we multiplexed a subset 
of single scRNAs (Fig.  4c). We based our constructs on 
our results obtained from single scRNAs, and previous 
reports showing transcriptional impact on production as 
a result of transcriptionally regulating pERG20, pERG9, 
and pHMG1 [7–9]. Additionally we targeted the repres-
sion of either pPGK1 or pTDH3 (Figs.  2a, 4c). When 
multiple scRNAs were introduced, we observed pheno-
typic changes relative to our control strain (Sc-124) for 
two of three constructs. In strain Sc-127, with scRNAs 
activating pHMG1 and pHMG2 while simultaneously 
repressing pERG9, the intensity of the carotenoid pig-
mentation increased in correlation with the design. For 
strain Sc-126, carrying scRNAs for repression of pERG20 
and pPGK1, while simultaneously activating pERG9, 
no change of pigmentation was observed. However, for 
both strains Sc-126 and Sc-127, no significant changes 
were observed in beta-carotenes (p = 0.12 and p = 0.05, 
respectively) (Fig.  4c). Contrastingly, for strain Sc-125, 
carrying scRNAs for repression of pERG20 and pTDH3 
and simultaneous activation of pERG9, a lighter yellow 
phenotype was observed which correlate with significant 
lowered beta-carotene content (p = 8.03E−06) (Fig. 4c). 
To rule out the possibility that regulated production was 
merely an attribute from reduced growth rate, we inves-
tigated the growth rate for all four strains (Fig. 4d). Here, 
we observed no negative effect on growth rates in any of 
the tested strains. The OD increase over time was similar 
between most strains including the control strain, except 
for Sc-125 that exhibited improved growth.
In our second test-bed, we investigated TAG biosyn-
thesis by regulating pOLE1 and pDGA1. To increase the 
precursor supply towards fatty acids and TAGs, a con-
stitutively active version acetyl coenzyme A carboxylase 
(ACC1) was expressed as previously reported [37]. When 
single best-performing gRNAs for pOLE1 and pDGA1 
were expressed together with dCas9-VPR, TAG levels 
increased 1.5-fold over WT, while double expression of 
gRNAs lead to >twofold increase after twenty-four hours 
(Fig.  5). While we were able to increase TAGs produc-
tion, reduction was not possible with the current setup 
(Additional file 6: Figure S5).
Taken together, the results from both the test beds 
demonstrate that transcriptional reprogramming of both 
linear and branched metabolic pathways is possible using 
the two different dCas9-mediated strategies.
Discussion
Native regulatory transcriptional networks are balanced 
to maintain cellular homeostasis and adapt towards 
defined environments [38, 39]. For the purpose of cell 
factory engineering this offers robustness, yet can impose 
challenges when introducing non-native biosynthetic 
pathways requiring high flux from native metabolic 
routes [29]. Deletion of native genes encoding metabolic 
pathway steps that compete with the heterologous meta-
bolic pathway is one approach used to perturb meta-
bolic fluxes towards the product(s) of interest. Yet, this 
can be challenging both in terms of numbers of genes to 
knock-out, but also in terms of maintaining cell growth 
if targeting essential genes. In addition to gene knock-
out strategies, re-directing metabolic fluxes by tuning 
the expression of essential genes encoding competing 
pathway steps is another strategy often used to improve 
biobased production. This has traditionally been accom-
plished by integrating inducible or repressible promot-
ers to control the expression of flux controlling genes 
amenable to transcriptional regulation [7, 29, 40]. More 
recently, CRISPR/dCas9 has been adopted for redirect-
ing metabolic fluxes through transcriptional regulation of 
single and multiple genes [21, 22, 24, 41]. With the results 
presented in our study using inducible CRISPR/dCas9 
and the scRNA-mediated combinatorial reprogram-
ming for scaffolding synthetic transcription machiner-
ies, metabolic engineers now have more tools to allow for 
inducible and multiplex control of expression of essential 
target genes, which simultaneously can sustain growth. 
In our study we observed no negative effects on growth 
when activating the inducible or constitutive CRISPR/
dCas9 systems (Additional file 2: Figure S1; Fig. 4d). This 
highlights the future potential of dCas9 as a simple tool 
for balancing between production of interest and growth, 
as also reported in E. coli [41]. Also, though S. cerevisiae 
is neither a natural producer of carotenoids, nor a pre-
ferred microbial cell factory for TAG biosynthesis, the 
renowned orthogonality of CRISPR/dCas9 should be 
amenable for implementation in natural carotenoid and 
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Fig. 4 Transcriptional regulation changes carotenoid production. a Yeast MVA pathway coupled to carotenoid production. Red triangles (repression 
with PCP-Mxi1) and green triangles (activation with MCP-VPR) illustrate the orientation of transcriptional regulation on selected promoters. pHMG1 
and pERG20 were targeted for regulation in up to two sites simultaneously, and pERG9 was either activated or repressed in different modules. b 
Nine strains (Sc-128 to Sc-136) are shown with single scRNAs targeting indicated promoters for regulation. Triangles indicate repression or activation 
as in a. Representative phenotypes including control (Sc-124) are presented next to respective constructs. c Left Individual scRNAs presented in 
b were multiplexed into three different designs. Triangles indicate reprogramming as in a. Right Quantification of β-carotene titers for each strain 
is presented. Values are shown as mean ± S.D. from three (n = 3) biological replicate experiments (*p < 0.01). d Growth assay depicting dry cell 
weight (DCW) per liter (g/L) as function of time for strains shown in c expressing multiplex scRNA designs for regulating carotenoid production. Blue 
Sc-124. Purple Sc-125. Green Sc-126. Red Sc-127. Presented data are averages of three biological replicates
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high-TAG producing hosts like Xanthophyllomyces den-
drorhous and Yarrowia lipolytica, respectively. Indeed, 
CRISPR/Cas9 has alsready been demonstrated in Yar-
rowia lipolytica [42].
In our study we have successfully tested two systems for 
transcriptional reprogramming by the use of well-charac-
terised phenotypes and selection, allowing us to retrieve 
variants harboring the desired properties (Figs.  4b, c, 
5). Still several features need to be improved in order to 
predictably engineer transcriptional reprogramming for 
desired phenotypes using RNA-guided dCas9. Firstly, 
in our study we have used currently available software 
for designing gRNAs focusing on (1) minimal off-target 
effects, (2) proximity of TSS, and (3) positioning within 
regions of low nucleosomal positioning. However, from 
our data it is evident that even state-of-the-art software 
tools are not able to reliably predict how specific gRNAs 
and scRNAs quantitatively interfere with the activity of 
a native promoter. For instance, though several studies 
have reported correlation between the relative expression 
level and the proximity of the gRNA position to TSS [23, 
30], this correlation is not evident when assessing our 
full library of tested scRNAs primarily targeting dcas9 
to the TSS-200 to TSS+1 window (Fig. 2b). Also, though 
we observed a strong correlation between the degree of 
nucleosomal occupancy of the scRNA target site and 
the transcriptional impact for pHMG1, for most of our 
14 target promoters this correlation was not prominent 
(Additional file  5: Figure S4). However, with respect to 
nucleosome positions, it is worth mentioning that infor-
mation obtained from S288C as reported in Kaplan et al. 
[33], may not be shared with the CEN.PK genome. In 
our study, the lack of data on nucleosome positioning in 
CEN.PK could have hampered identification of appropri-
ate target sites for scRNAs. Another feature which should 
be considered for optimizing transcriptional reprogram-
ming is using other dCas9 variants. Recently Cas9/dCas9 
hotspots for engineering were mapped [43], and these 
present an opportunity to build additional domains into 
dCas9. If transcriptional regulation is a matter of titration 
of transcriptional effectors, introducing such domains 
into dCas9 hotspots could potentially facilitate, and fur-
ther potentiate transcriptional regulation [43]. Such 
a modified dCas9 could function in addition to direct 
fusions between dCas9 and Mxi1, and in particular VPR, 
to enhance transcriptional regulation. Similarly, the use 
of smaller Class 2 RNA-guided nuclease effectors may 
improve the transcriptional activation potential by limit-
ing potential sterical hindrance of the RNA polymerase 
[44]. Having said this, once identified, effective gRNAs 
enable transcriptional reprogramming over time as evi-
denced from our time-resolved reporter assays (Fig.  3c; 
Additional file 3: Figure S2).
Finally, though both strategies tested in this study 
performed similarly on pHMG1, it is evident that the 
systems offer different advantages, which should be 
considered depending on the application. The inducible 
system can easily be turned into a one-plasmid strategy, 
which maintains inducible control over one or more 
gRNA expression cassettes. Likewise, this system offers 
external tuning of expression. The constitutive system on 
the other hand, can also be greatly expanded as recently 
demonstrated by the coupling of the PP7 RNA scaffold 
to bacterial small-molecule-regulated protein degron 
domains in order to support conditional activation [45]. 
This additional layer to scaffold-mediated transcriptional 
regulation makes it a very powerful tool for future use.
Taken together, this work has provided valuable infor-
mation on transcriptional regulation using dCas9 in 
direct and indirect fusions to transcriptional effectors 
in yeast. Though there is a need for further refining the 
tools, our results provide the framework for future work 
on pathway regulation in yeast and further investigations 
for improving computer-aided design rules for gRNA 
design.
Conclusion
In conclusion our study shows a similar performance of 
two different dCas9-mediated strategies for control of 
gene expression. Following testing >100 gRNAs we used 
combinations of the best-performing ones to reprogram 
yeast cells towards changes in production of carotenoids 
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Fig. 5 Triacylglycerol quantification after induced transcriptional 
regulation. TAG production was engineered in three strains; single 
gRNAs targeting positions TSS-139 on pDGA1 (pERA-122 in Sc-164) 
and TSS-381 on pOLE1 (pERA-112 in Sc-162) and multiplexed expres-
sion of both gRNAs coupled to dCas9-VPR (pERA-132 in Sc-166). 
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replicate experiments with asterisks indicating significant changes in 
triacylglycerol content relative to the control strain (*p < 0.05)
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and TAGs. As some of the gRNA targets used in this 
study are essential genes, the design and selection of effi-
cient gRNAs identified in this study are promising valves 
for prospecting, balancing and optimization of pathway 
flux without the need for genome engineering. Moreover, 
the testbeds used in the study are of strong interest for 
biobased production of value-added chemicals and fuels, 
and hence should be of of broad interest to the metabolic 
engineering community.
Methods
Strain and plasmid construction
Plasmids, strains and primers used in this study are listed 
in Additional file 7: Table S1, Additional file 8: Table S2, 
Additional file 9: S3 1. Oligonucleotides and gBlocks were 
ordered from IDT and Eurofins. All fragments obtained 
by PCR were gel- or column purified (Nucleospin® Gel 
and PCR Clean-up columns) before cloning, and result-
ing plasmids were verified by sequencing (Eurofins). 
Yeast transformations were done using lithium acetate 
and PEG3350, and genomic integrations were performed 
with various helper plasmids and pre-expressed iCas9 
from plasmid pCT (Addgene #60620) and plated on Sc-
Leu+cloNAT. Strains were cured for pCT and helper 
plasmids after genome engineering and before proceed-
ing to transcriptional regulation using dCas9.
EasyClone-MarkerFree vectors pCfB2909, pCfB3035, 
pCfB3037 and helper plasmids pCfB3042, pCfB3046, 
and pCfB3050 as well as genomic integration verifica-
tion primers were adapted as previously described [46]. 
Yeast strains were plated according to auxotrophies and 
plasmid markers. Mxi1 [18] and PCP [24] were fused 
with pADH1 into pCfB3035 to create a transcription-
repressing construct for genomic integration. pADH1 
was obtained by PCR amplification of genomic DNA 
with primers pADH1_fw and pADH1_rv. Mxi1 was PCR 
amplified from Addgene plasmid #46921 with primers 
EDJ-126 and EDJ-127. The PP7 RNA scaffold-binding 
protein PCP was PCR amplified from gBlock gEDJ-9 
with primers EDJ-124 and EDJ-125. Mxi1 was USER 
assembled with pADH1 and PCP into SfaAI/Nb.BsmI 
pre-digested vector pCfB3035, resulting in plasmid pEDJ-
22. The PCP-Mxi1 fusion was intervened by a 3× GS 
linker. The transcriptional enhancer [25] was obtained 
from Addgene plasmid #63801 by PCR with primers 
EDJ-098 and EDJ-099. The 2× (wt +  f6) RNA scaffold-
binding protein MCP [24] was obtained by PCR ampli-
fication of gEDJ-7 using primers EDJ-096 and EDJ-097. 
VPR was USER assembled with pADH1 and MCP into 
SfaAI/Nb.BsmI pre-digested vector pCfB3037, resulting 
in plasmid pEDJ-87. In this construct, a 1× GS linker 
and SV40-NLS separate MCP from VPR. pEDJ-22 and 
pEDJ-87 were digested by NotI and purified on column 
before transformation. Digests were sequentially inte-
grated using helper plasmids pCfB3042 and pCfB3046, 
respectively, into S. cerevisiae strain CEN.PK102-3A. The 
resulting integrations into EasyClone-MarkerFree sites 
X-4 (pEDJ-22) and XI-5 (pEDJ-87) defined a new strain, 
Sc-10. Integration at EasyClone-MarkerFree site X-4 was 
verified by genomic integration verification primer pairs 
2221 and 905, 2220 and 906, 905 and 906, and integra-
tion at EasyClone-MarkerFree site XI-5 was verified by 
genomic integration verification primers 2221 and 8418, 
2220 and 8419, and 8418 and 8419.
Next, promoter-GFP fusions were made with 12 
individual yeast promoters obtained by using primers 
ERA-1 to ERA-24 on S. cerevisiae strain CEN.PK113-7D 
genomic DNA, and GFP obtained by PCR with primers 
GFPopt_fw and GFPopt_rv on p416TEF-GFP. Promoter-
GFP fusions were USER assembled into SfaAI/Nb.BsmI 
pre-digested vector pCfB2909. Resulting plasmids 
pERA-1 to pERA-12 were digested by NotI and inte-
grated in yeast strain Sc-10 into EasyClone-MarkerFree 
site XII-5 using helper plasmid pCfB3050, thus constitut-
ing strains Sc-11 to Sc-22. Plasmids pERA-13 and pERA-
14 were assembled by USER cloning and express dCas9 
from pTDH3 and pTEF1, respectively. The dCas9 ORF 
was amplified by PCR from plasmid Addgene (#63801) 
with primers EDJ-204 and EDJ-205. pTDH3 was gener-
ated by PCR amplification of genomic DNA with primers 
Tdh3p_fw and Tdh3p_rv, and pTEF1 was obtained from 
amplification of p0029 [47] with primers Tef1p_fw and 
Tef1p_rv. Assemblies were done into plasmid pRS415U 
pre-digested with SfaAI/Nb.BsmI to constitute the final 
plasmids pERA-13 and pERA-14. Plasmid pERA-13 was 
transformed into Sc-11 to Sc-14 and Sc-16 to Sc-22 to 
yield the new strains Sc-23 to Sc-26 and Sc-28 to Sc-34. 
Sc-15 was transformed with pERA-14, making up strain 
Sc-27. Addgene plasmids pJZC603 (#62317) [24] car-
rying the 2xPP7 scRNA scaffold and pJZC588 (#62315) 
[24] containing the 2× (wt  +  f6) scRNA scaffold were 
inversely PCR amplified with forward primer ERA-37 
and reverse primer TJOS-20 [48] and blunt-end ligated 
by T4 DNA ligase (NEB) and digested by DpnI before 
transformation into E. coli strain DH5-α and plasmid 
purification, resulting in plasmids pEDJ-51 and pEDJ-
52, respectively. Primers EDJ-216 and EDJ-221 ampli-
fied the scRNA cassettes from pEDJ-51 and pEDJ-52 that 
were subsequently used in a USER-assembly into SfaAI/
Nb.BsmI pre-digested USER plasmid p0054 [47], gen-
erating plasmids pERA-39 and pERA-40, respectively. 
Plasmids pEDJ-51 and pEDJ-52 served as templates for 
forward primers ERA-25 to ERA-68 paired with reverse 
primer TJOS-20 to generate plasmids pERA-15 to pERA-
102 harboring gRNA1 to gRNA44 attached to 2× PP7 or 
2× (wt  +  f6) scaffolds. Plasmids pERA-15 to pERA-44 
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and pERA-53 to pERA-102 were co-transformed with 
pERA-13 into strains Sc-11 to Sc-14 and Sc-16 to Sc-22, 
respective to integrated promoter-GFP constructs, to 
create strains Sc-35 to Sc-64 and Sc-73 to Sc-122. pERA-
45 to pERA-52 were co-transformed with pERA-14 into 
strain Sc-15 to create strains Sc-65 to Sc-72. Resulting 
transformants were used for fluorescence analysis. Mul-
tiplex scRNA plasmids for regulating carotenoid produc-
tion were generated as described [48] and outlined below, 
using PhusionU for polymerization.
For generation of multiplex gRNA plasmid pERA-103, 
plasmid pERA-86 served as template for primers EDJ-216 
and EDJ-217, plasmid pERA-67 as template for primers 
EDJ-218 and EDJ-219, and plasmid pERA-48 as tem-
plate for primers EDJ-220 and EDJ-221. All three frag-
ments were gel purified and USER-assembled into SfaAI/
Nb.BsmI digested plasmid p0054. To generate the multi-
plex gRNA plasmid pERA-104, plasmid pERA-86 served 
as template for primers EDJ-216 and EDJ-217, plasmid 
pERA-85 as template for primers EDJ-218 and EDJ-226, 
plasmid pERA-29 as template for primers EDJ-219 and 
EDJ-225, and plasmid pERA-67 as template for primers 
EDJ-220 and EDJ-221. Assembly was performed as for 
generating pERA-103. For generation of multiplex gRNA 
plasmid pERA-105, plasmid pERA-95 served as template 
for primers EDJ-216 and EDJ-217, plasmid pERA-96 as 
template for primers EDJ-218 and EDJ-226, plasmid 
pERA-62 as template for primers EDJ-219 and EDJ-225, 
and plasmid pERA-100 as template for primers EDJ-220 
and EDJ-221. Assembly was done as for generating plas-
mids pERA-103 and pERA-104. All gRNA sequences are 
listed in Additional file 1: Table S4.
Strain Sc-10 was further engineered to express the 
carotenoid pathway previously described [27]. The con-
structs were made as according to [46]. pPGK1 and BTS1 
was USER cloned into pCfB2903 and called pTAJAK-182. 
pTDH3 and crtI was USER cloned into pCfB3034 and 
called pTAJAK-183. pTEF1 and crtYB was USER cloned 
into pCfB3039 and called pTAJAK-184. After NotI diges-
tion, all three constructs were transformed into Sc-10 
pre-expressing pCT and with pCfB3051 for Cas9-guided 
integration. pERA-13 and p0054 co-transformed Sc-123 
to yield Sc-124 serving as control (no regulation) on carot-
enoid production. pERA-14 and pERA-103 co-transformed 
Sc-123 to give Sc-125. pERA-13 transformed Sc-123 with 
pERA-104 or pERA-105 to give strains Sc-126 or Sc-127, 
respectively. pERA-14 cotransformed Sc-123 with pERA-
48 resulting in Sc-129. Sc-123 was also transformed by 
pERA-13 in combination with pERA-29, pERA-62, pERA-
67, pERA-85, pERA-86, pERA-95, pERA-96, or pERA-100 
making up strains Sc-128 and Sc-130 to Sc-136.
The plasmid pERA-109 was constructed by ampli-
fying the VPR using VPR-F and VPR-R primers from 
pAG414GPD-dCas9-VPR plasmid (Addgene #63801). 
The PCR fragment was treated with DpnI, gel puri-
fied and inserted with Gibson assembly [49] into plas-
mid pRS414-Tef1-NLS-dCas9-Cyc1 [23] at the PacI site. 
pOLE1 was amplified from CEN.PK113-11C genomic 
DNA using OLE1promoter-F and OLE1promoter-R pair 
of primers. GFP was amplified from p416TEF-GFP plas-
mid using OLE1gfp-F and GFP-R pair of primers. The 
vector p413-TEF (ATCC® 87362™) was amplified with 
pair of primers annealing outside the TEF promoter 
region using p413-F and p413-R primers. pOLE1, GFP 
and p413 PCR fragments were cloned together using 
Gibson Assembly to create pERA-110. pDGA1 was 
amplified from CEN.PK113-11C genomic DNA. GFP 
was amplified from p416TEF-GFP using DGA1gfp-F and 
GFP-R. pDGA1, GFP, and p413-TEF PCR fragments were 
cloned together using Gibson Assembly to make pERA-
111. gRNAextender-F/R gRNAextender-R primers ampli-
fied ERA-69 to ERA-79 that were subsequently cloned 
into pERA-109 and dCas9-Mxi according to Smith 
et  al. [23], constituting pERA-112 to pERA-131 harbor-
ing gRNA45-gRNA54 and also pERA-134 and pERA-
135 harboring gRNA39. Correct clones were confirmed 
with colony PCR using 3 primers (62-pRPR1-NotI-fwd, 
49-pRPR1_fwd and 74-RPR1t-5′-Rev). The multiplexed 
pOLE1/pDGA1 gRNA expression plasmid was built by 
amplifying from the plasmids pERA-112 using Multi-
plex1 and Multiplex2 pair of primers, and, pERA-113 
using Multiplex3 and Multiplex4 pair of primers. The two 
PCR fragments were cloned into pERA-109 and dCas9-
Mxi in NotI by Gibson assembly to generate pERA-132 
and pERA-133 both harboring gRNA45 and gRNA46. 
Plasmid pERA-110 and pERA-111 were transformed into 
CEN.PK-11C to yield the new strains Sc-137 and Sc-138 
respectively. Sc-137 was transformed with pERA-109 
and pERA-112 to pERA-121 making up strain Sc-139 to 
Sc-149. Sc-138 was transformed with pERA-109 alone 
and with pERA-122 to pERA-131 individually, making up 
strains Sc-150 to Sc-160. For TAG quantification, CEN.
PK-11C with HXT7p-ACC1**-CYC1t at X-2 site (Sc-180) 
was transformed with pERA-109, pERA-112, pERA-117, 
pERA-122, pERA-127, pERA-132 and pERA-133 mak-
ing up strains Sc-161 to Sc-167. Primers OLE1-GFP_F/
OLE1-GFP_R amplified template pERA-110 to obtain 
pOLE1-GFP that was transferred to pCfB2909. Co-trans-
forming the resulting NotI prepared fragment with helper 
plasmid pCfB3050 integrated pOLE1-GFP in CEN.
PK102-3A produced strain Sc-168. Plasmids pERA-109, 
pERA-112 and pERA-117 were transformed into Sc-168 
making up strains Sc-169 to Sc-171. Strain Sc-172 was 
generated from integrating pHMG1-GFP exactly as for 
creating strain Sc-21, but using CEN.PK102-3A as host 
strain instead of Sc-10. Plasmids pERA-109, pERA-134 
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and pERA-135 were transformed into Sc-172 making 
up strains Sc-173 to Sc-175. Plasmids pERA-109, pERA-
122 and pERA-127 were transformed into Sc-176 mak-
ing up strains Sc-177 to Sc-179. Primers OLE1-GFP_F/
OLE1-GFP_R amplified template pERA-110 to obtain 
pOLE1-GFP. The fragments were USER-assembled into 
plasmid pCfB2909 followed by NotI digestion and inte-
gration into strain Sc-10 at EasyClone-MarkerFree site 
XII-5 using helper plasmid pCfB3050, resulting in strain 
Sc-176. Plasmids pERA-107 and pERA-108 were made 
by inverse amplification of pERA-94 with primers TJOS-
20 and gRNA45_F. Sc-176 was transformed by pERA-13 
alone and with either pERA-107 or pERA-108 making 
up strains Sc-177, Sc-178 and Sc-179 that were used for 
benchmarking the constitutive and inducible systems.
Activating the inducible system
For cultivations in shake flasks, 5 mL of minimal medium 
was inoculated with a single colony from selective 
medium and incubated at 200 rpm and 30 °C O/N. Sub-
sequently, the pre-culture was used to inoculate 10 mL of 
minimal medium with 250 ng/mL of aTc in shake flasks 
without baffles and a total volume of 100 mL at an OD600 
of 0.05.
Flow cytometer analysis
Transformants carrying the dCas9-expression plasmids 
pERA-13 or pERA-14 only were inoculated in liquid Sc-
Leu, and strains additionally carrying pERA-15 to pERA-
102 were inoculated in liquid Sc-Leu-Ura and incubated 
at 30  °C with agitation O/N. Cultures were passed the 
next day, 24 h before analysis, in 10× dilutions to fresh 
media and incubated at 30  °C with shaking. Then 30 μL 
of each culture was transferred into 150 μL of Phosphate 
Buffer Saline (PBS) from Life Technologies for analysis. 
The Guava easyCyte™ from EMD Millipore was used to 
analyse GFP intensity from 10,000 single-cells per cul-
ture with a blue laser at 488  nm, and FlowJo software 
(TreeStar Inc.) was used for processing events. At least 
three biological replicates were analysed, and arithmetic 
mean fluorescense for each population was determined. 
Error bars correspond to the deviation between replicate 
cultures, and fold-changes were calculated by dividing 
means from ’activated’ cultures with ’control’ cultures.
BioLector cultivations
DCW, OD and GFP signals were recorded using a Bio-
Lector (m2p-labs, Baesweiler, Germany). For this pur-
pose, at least three biological replicates were picked 
from selective medium and each used to inoculate 3 mL 
of Synthetic Medium followed by O/N incubation at 
30 °C and 200 rpm. Cultures were each used to inoculate 
1 mL of SC at an OD600 of ~0.2 for the inducible system. 
Subsequently, the cultures were transferred into a 48-well 
microtiter plate (MTP-48-B FlowerPlate, m2p-labs) and 
incubated at 30 °C and 1000 rpm using the BioLector. The 
optical density was measured on-line in 15 min intervals 
at filter gain 20 for the inducible system and filter gain 10 
for the constitutive system. The fluorescence signal was 
measured at the filter gain 50 for the inducible system 
and filter gain 100 for the constitutive system.
Transcriptional start site localization
Locations of TSSs were obtained from Miura et  al. [50] 
and annotated via http://lp2.github.io/yeast-crispri/ [23].
Carotenoid extraction procedure
Four replicates from whole-plate scrapings were dis-
solved in 5  mL Sc-Leu-Ura and incubated with shaking 
(250 rpm) at 30 °C for 72 h. Outgrown cultures were cen-
trifuged at 3000 rpm for 3 min and supernatant discarded 
by pouring. Remaining supernatant was used to resus-
pend cell pellet and was transferred to 1.5 mL Eppendorf 
tubes. The tubes were centrifuged at 3000 rpm for 3 min 
and supernatant removed by pipetting. Cell pellet was 
resuspended in 250 μL Glucanex (Sigma-Aldrich) to the 
final concentration 1  mg/25  μL and incubated at 37  °C 
for 30  min. 300  μL hexane (Sigma-Aldrich) was added 
to each tube, and total volume was transferred to a 2 mL 
screw cap micro tube (Sarstedt) containing 0.25 mL acid 
washed glass beads (Sigma-Aldrich). Samples were run 
on a Precellys 24 homogenizer (Bertin Instruments) at 
4 × 40 s at 6500 rpm. After extraction, hexane was sep-
arated from beads and pale cell pellet by centrifugation 
at 13,000g for 3 min. Hexane phase was transferred to a 
fresh 1.5 mL Eppendorf tube. 40 μL of each sample was 
transferred to a fresh 1.5  mL Eppendorf tube, and hex-
ane was evaporated in a fume hood at room temperature. 
Dried content was resuspended in 1  mL 100% ethanol, 
and 150 μL was moved to a new vial for analysis.
β‑Carotene quantification
LC–MS analysis was performed with Orbitrap Fusion 
equipped with a Dionex Ultimate 3000 UHPLC pump-
ing system (ThermoFisher Scientific, Waltham, MA, 
USA). Samples were held in the autosampler under 
10.0  °C during the analysis. 7  μL of each sample was 
injected to a Supelco Discovery HS F5-3 HPLC column 
(2.1  ×  150  mm, 3  μm), at a flow rate of 0.7  mL/min, 
30.0  °C. Mobile phases A and B were 0.1% formic acid 
in water and acetonitrile, respectively. Elution was done 
with a 25 min multistep system. After 25% B for 3 min, a 
linear gradient started from 25% B to 100% B in 12 min, 
which was held for another 5  min and followed by re-
equilibration to 25% B until 25 min. The column eluent 
flowed directly into the heated ESI probe of the MS which 
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was held at 325  °C and a voltage of 3500 V. Profile data 
was collected in positive ion mode with resolution set-
ting of 30 K and scan range (m/z) = 200–1000. Other MS 
setting parameters were as follows: sheath gas flow rate 
of 60 units, Aux gas flow rate of 20 units, sweep gas flow 
rate of 5 units, ion transfer tube temp was 380 °C, maxi-
mum injection time of 100  ms, S-lens RF level =  60  V, 
using 1 Microscans and AGC target  =  200,000 counts. 
Carotene (m/z 536.4372, [M+H]+) was eluted at reten-
tion time 14.8 min. To quantify with bracketing calibra-
tion method, carotene standards with calibration ranging 
1.0–30.0  µg/mL were prepared and measured together 
with all samples. Further processing was carried out 
using Thermo Xcalibur 3.0.
TAGs quantification
Samples for lipid analysis were taken after 24 h of shake 
flask cultivation. Subsequently, the samples were centri-
fuged at 2000 rcf and the supernatant was discarded. The 
pellets were kept at −20 °C for 15 min and then freeze-
dried using a Christ alpha 2–4 LSC (Christ Gefrier-
trocknungsanlagen, Osterode, Germany). For all samples 
10 mg of freeze-dried biomass were transferred into the 
extraction tubes. 50 μg of Cholesterol (1 mg/mL): Inter-
nal standard was added in the samples and the blanks. 
7 mL of CHCl3:MeOH (2:1) and N2 gas was flushed into 
the tube to remove the air. After vortexing the tubes 
for 1 min, the tubes were put into the microwave vessel 
containing 30  mL water inside and then placed in the 
microwave. Samples were heated from room tempera-
ture to 60 °C (within 6 min) and kept at 60 °C for 10 min. 
1.7 mL of 0.73% NaCl were added after the samples were 
cooled down to room temperature. After vortexing for 
20 s, the tubes were centrifuged at 3000 rpm for 5 min. 
The organic phase was transferred into clean extraction 
tubes. The sample were dried with MiVac Evaporator and 
re-suspended with 200  μL of CHCl3:MeOH (2:1). Sam-
ples were then analysed via HPLC-CAD as described by 
[51].
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Additional file 1: Table S4. gRNA sequences and target information.
Additional file 2: Figure S1. Growth kinetics during transcriptional 
regulation of pHMG1 and pOLE1. Indicated strains were the same as in 
Fig. 1C targeted for regulation at pHMG1 or pOLE1, with controls (ctrl) 
expressing dCas9 and no gRNA. Growth was monitored over ~47 hours 
with a BioLector, and presented data is the average of three biological rep-
licates. A. Strains that harbored the constitutive system were monitored 
for increasing dry cell weight (DCW) per liter (g/L) for controls (blue), 
activation with MCP-VPR (green), and repression with PCP-Mxi1 (red). B. 
Strains that contained the inducible system were cultured with 250 ng/
mL aTc, and OD600 was monitored. Blue indicates control cultures (dCas9), 
green activation (dCas9-VPR), and red repression (dCas9-Mxi1).
Additional file 3: Figure S2. Time-dependent regulation of reporter 
gene expression. Data were obtained with a BioLector from the same 
cultures as used in Supplementary Fig. S1. Indicated strains were targeted 
at pHMG1 or pOLE1 as in Fig. 1C with controls (ctrl) expressing dCas9 and 
no gRNA. Data were collected for ~47 hrs and are presented as the aver-
age of three biological replicates. A. MFI from strains targeted with the 
constitutive system is presented per DCW/L (dry cell weight per liter) as a 
function of time. Blue; control. Green; activation (MCP-VPR). Red; repres-
sion (PCP-Mxi1). B. MFI from cultures added 250 ng/mL aTc to activate 
the inducible system is presented per OD (OD600) over time. Blue; control. 
Green; activation (dCas9-VPR). Red; repression (dCas9-Mxi1).
Additional file 4: Figure S3. CRISPR/dCas9-mediated regulation of 
twelve native yeast promoters. Twelve yeast promoters as indicated were 
targeted with scRNAs in a total of 88 strains for regulation at various posi-
tions. Deviations from ’no gRNA’ control for each promoter is shown on 
second axis (relative MFI), and promoters with indicated distances from 
scRNA hybridization sites to TSS+1 are listed on first axis. Dark grey bars 
represent regulation with MCP-VPR (activation) and light grey bars regula-
tion with PCP-Mxi1 (repression). GFP emission was measured following 24 
hrs incubation and MFI calculated. MFI values are shown as mean ± s.d. 
from three (n = 3) biological replicate experiments (* = p < 0.01).
Additional file 5: Figure S4. Transcriptional regulation vs. nucleosome 
occupancy. Relative MFI (deviation from ’no gRNA’ control) is shown on 
second axis vs. predicted nucleosome occupancy on first axis for 12 yeast 
promoters. Predicted nucleosome occupancies were based on Kaplan 
et al. [33] and are the averaged values between the 5’- and 3’-most occu-
pancy values of gRNAs. Low predicted nucleosome occupancy scores 
relate to lower nucleosome densities at a given position. Dark grey sym-
bolizes regulation with MCP-VPR (activation) and light grey with PCP-Mxi1 
(repression). Results are based on at least three biological replicates.
Additional file 6: Figure S5. Triacylglycerol quantification after induced 
transcriptional regulation for both activator and repressor. TAG production 
was engineered in three yeast strains; single gRNAs targeting position TSS-
139 on pDGA1 (Sc-164 and Sc-165; pERA-122, pERA-127) and TSS-381 on 
pOLE1 (Sc-162 and Sc-163: pERA-112, pERA-117) and multiplexed expres-
sion of both gRNAs coupled to dCas9-VPR (Sc-166 and Sc-167: pERA-132, 
pERA-133). The strains were cultivated in shake flasks for twenty-four 
hours at 200 rpm, 30 °C. Results are based on three biological replicates. 
Significant changes are indicated by asterisk.
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Additional file 9: Table S3. Primers.
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